1. Home
  2. XOMA

XOMA

XOMA Corporation

Logo XOMA Corporation

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Founded: N/A Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 282.1M IPO Year: N/A
Target Price: $74.00 AVG Volume (30 days): 19.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.04 EPS Growth: N/A
52 Week Low/High: $13.48 - $27.00 Next Earning Date: 05-07-2024
Revenue: $4,758,000 Revenue Growth: -21.06%
Revenue Growth (this year): 202.27% Revenue Growth (next year): 46.45%

Share on Social Networks: